BioSpace News Archive

The “State of Cybersecurity” event features cybersecurity expert panelists Chris Blask and Chuck Brooks, and Cybeats co-founder and CTO, Dmitry Raidman.

The global clinical trial supplies market is expected to reach US$ 3,298.91 Mn in 2027 from US$ 1,867.44 Mn in 2019.

The healthcare contract research organizations (CRO) services market is expected to reach US$ 87,859.08 million by 2027 from US$ 43,208.57 million in 2019.

The report highlights the trends prevailing in the market, along with market drivers and deterrents.

The market is estimated to grow with a CAGR of 8.8% from 2020 to 2027.

A computerized brain implant effectively relieves short-term and chronic pain in rodents, a new study finds.

Venatorx Pharmaceuticals today announced that it will present at the International Liver CongressTM (ILC), the European Association for the Study of the Liver (EASL) annual meeting, which is scheduled to take place virtually June 23-26, 2021.

POXEL SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis announced its participation at the European Association for the Study of the Liver International Liver CongressTM which will be held from June 23-26, 2021.

Halberd Corporation’s proprietary technology enters stage 4 to address Alzheimer’s Disease (and other potential diseases); eradicating the antibody-disease combination through radiofrequency waves or laser or other means.

Bruker Corporation today announced the launch of a new VIP-HESI ion source to increase sensitivity dramatically, and new integrated software tools to increase confidence in 4D-Metabolomics and 4D-Lipidomics workflows.